Hans Baumeister

Title: Innovations of Hans Baumeister in Antibody Production

Introduction

Hans Baumeister, an influential inventor based in Berlin, Germany, has made significant contributions to the field of biotechnology. With a total of six patents to his name, Baumeister continues to push the boundaries of science, particularly in the area of protein production using human cells.

Latest Patents

One of Baumeister's noteworthy inventions focuses on the use of human cells of myeloid leukemia origin for the expression of antibodies. This innovative method involves producing a protein molecule composition with a defined glycosylation pattern. It comprises the introduction of at least one nucleic acid encoding part of the desired protein into an immortalized human blood cell. Subsequently, the host cell is cultured under optimal conditions to permit protein composition production and finally isolating the resulting protein molecule.

Career Highlights

Throughout his career, Baumeister has worked with prominent companies, including Glycotope GmbH and Glycotype GmbH. His tenure at these organizations has provided him with valuable experience in the biotechnology sector, fostering his innovations and enhancing his expertise in protein production techniques.

Collaborations

In the course of his career, Baumeister has collaborated with notable colleagues, including Steffen Goletz and Ute Schöber. These partnerships have contributed to the advancement of his research and innovations, showcasing the importance of teamwork in the field of scientific discovery.

Conclusion

Hans Baumeister's contributions to the field of biotechnology, particularly through his patents for innovative methodologies in protein production, underscore the vital role inventors play in advancing science and technology. His work continues to inspire future innovations in both academic and commercial settings, making a significant impact on the world of biomedical research.